Aspira Pathlab Current Share Price | Aspira Pathlab Stock Screener
ASPIRA
Healthcare Service Provider
Aspira Pathlab Current Stock Price Today
Live Share Price BSE
₹115.00
▲
5.47 (4.99%)
As of September 18, 2026, the live Aspira Pathlab share price (BSE: ASPIRA) is ₹115.00, up 4.99% from the previous close, with shares trading between ₹115.00 and ₹115.00 in today's trading session, and a 52-week range of ₹54.00–₹133.29.
Browse Aspira Pathlab annual reports to support your investment research.
Use the Aspira Pathlab stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Aspira Pathlab Market Cap
₹102.17 Cr.
ASPIRA P/E Ratio (TTM)
40.77
Aspira Pathlab P/B Ratio
13.45
EPS (TTM)
₹1.97
Dividend Yield
-
Debt to Equity
0.15
ASPIRA 52 Week High
₹133.29
Aspira Pathlab 52 Week Low
₹54.00
Operating Margin
16.00%
Profit Margin
16.67%
ASPIRA Revenue (TTM)
₹6.00
EBITDA
₹1.00
Net Income
₹1.00
Total Assets
₹18.00
Total Equity
₹12.00
Aspira Pathlab Current Share Price Chart
Track the current Aspira Pathlab share price and stock price with an interactive chart. Analyse ASPIRA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Aspira Pathlab stock quote in one place.
Aspira Pathlab Company Profile - Fundamental Screener
Screen Aspira Pathlab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ASPIRA shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE500C01017
Aspira Pathlab Balance Sheet Screener
Screen ASPIRA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 |
|---|---|---|
| Assets | ||
| Total Assets | 18 | 15 |
| Current Assets | 5 | 4 |
| Fixed Assets | 7 | 7 |
| Liabilities | ||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 3 | 3 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 12 | 10 |
| Share Capital | 10 | 10 |
| Reserves & Surplus | -3 | -5 |
Aspira Pathlab Income Statement Screener - Profit & Revenue Analysis
Screen Aspira Pathlab income statement and profit fundamentals.
Analyze ASPIRA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Aspira Pathlab share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Jun |
|---|---|---|---|---|---|---|---|
| Revenue | 6 | 5 | 4 | 5 | 6 | 6 | 3 |
| Expenses | 5 | 5 | 4 | 4 | 5 | 5 | 3 |
| EBITDA | 1 | 1 | 0 | 0 | 1 | 1 | 0 |
| Operating Profit % | 16.00% | 13.00% | -5.00% | 6.00% | 21.00% | 11.00% | -17.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 0 | -1 | 0 | 1 | 0 | -1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 0 | -1 | 0 | 1 | 0 | -1 |
| EPS | 0.66 | 0.41 | -0.49 | 0.05 | 0.96 | 0.30 | -0.70 |
Aspira Pathlab Cash Flow Screener - Liquidity Fundamentals
Screen ASPIRA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March |
|---|---|---|
| Operating Activities | 2 | 1 |
| Investing Activities | 0 | 0 |
| Financing Activities | -1 | -1 |
| Net Cash Flow | 1 | 0 |
Aspira Pathlab Shareholding Pattern Screener
See Aspira Pathlab shareholding pattern with promoter, FII, and DII holdings.
Check Aspira Pathlab promoter holding and ownership changes for ASPIRA on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 46.58% | 18.39% | 18.39% | 18.39% | 18.39% | 18.39% | 18.55% | 18.55% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 40.70% | 60.06% | 60.07% | 60.16% | 60.28% | 60.46% | 60.28% | 61.26% |
| Other Holding | 12.72% | 21.55% | 21.54% | 21.45% | 21.33% | 21.15% | 21.18% | 20.19% |
| Shareholder Count | 1,620 | 1,769 | 1,784 | 1,755 | 1,770 | 1,741 | 1,593 | 1,706 |
Aspira Pathlab Share Dividend Screener - Share Yield Analysis
Check Aspira Pathlab dividend history with payout and yield data.
View Aspira Pathlab dividend details including ex-dates and amounts for ASPIRA stock.
Aspira Pathlab Stock Index Membership
See which indices include Aspira Pathlab stock.
Check ASPIRA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Aspira Pathlab Market Events Screener - Corporate Actions
Get Aspira Pathlab corporate actions including splits, bonuses, and buybacks.
Check Aspira Pathlab stock events that may affect ASPIRA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-25 | 2026-09-25 | Annual General Meeting | NA | 3.83% |
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | -7.64% |
| 2026-05-23 | 2026-05-23 | Quarterly Result Announcement | NA | 24.57% |
| 2026-02-10 | 2026-02-10 | Quarterly Result Announcement | NA | 13.68% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -0.33% |
| 2025-09-26 | 2025-09-26 | Annual General Meeting | NA | -1.79% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -6.20% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | -12.33% |
| 2025-02-07 | 2025-02-07 | Quarterly Result Announcement | NA | -9.00% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 23.16% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | 27.67% |
| 2016-11-16 | 2016-11-16 | Change Of Name | NA | - |
Aspira Pathlab Competitors Screener - Peer Comparison
Screen ASPIRA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 31,958 | 58.66 | 2,864 | 12.11% | 510 | 52.85 |
| Vijaya Diagnostic Centre | 14,855 | 82.54 | 835 | 19.34% | 173 | 44.95 |
| Metropolis Healthcare | 11,870 | 59.91 | 1,671 | 24.15% | 191 | 48.12 |
| Thyrocare Technologies | 8,666 | 49.62 | 846 | 20.48% | 163 | 37.31 |
| Nephrocare Health Services | 7,375 | 90.61 | 1,023 | 32.93% | 77 | 57.75 |
| Krsnaa Diagnostics | 1,757 | 18.39 | 773 | 4.05% | 106 | 43.89 |
| Suraksha Diagnostic | 1,682 | 48.15 | 314 | 22.55% | 31 | 54.61 |
| 3B BlackBio DX | 1,164 | 21.72 | 142 | 27.17% | 61 | 49.35 |
| One Global Service Provider | 1,013 | 14.36 | 499 | 237.48% | 70 | 39.84 |
| Health X Platform | 972 | -37.44 | 1,319 | 12.68% | -3 | 53.22 |
Aspira Pathlab Company Announcements - News Screener
Screen ASPIRA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-16 | Announcement Under Regulation 30_Constitution Of Right Issue Committee | - |
| 2026-09-16 | Announcement under Regulation 30 (LODR)-Raising of Funds | - |
| 2026-09-16 | Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th September 2026 | - |
| 2026-09-16 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-11 | Board Meeting Intimation for To Consider Approve The Proposal For Raising Funds Through The Issuance Of Equity Shares Warrants Convertible Into Equity Shares Or Other Permitted Instruments By Way Of Preferential Issue Private Placement Rights Issue Or Any | - |
| 2026-09-09 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-03 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-01 | Letters Dispatched To Non-Email Shareholders | - |
| 2026-09-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-31 | Reg. 34 (1) Annual Report. | - |
| 2026-08-31 | Notice Convening 53Rd Annual General Meeting To Be Held On Friday September 25 2026 At 02.00 P.M Through Video Conferencing Mode. | - |
| 2026-08-31 | Intimation Of Book Closure Date Notice Of The 53Rd Annual General Meeting And E-Voting Date | - |
| 2026-08-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-12 | Unaudited Standalone Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August 2026 | - |
| 2026-08-06 | Board Meeting Intimation for Approval Of Un-Audited Financial Result (Standalone) For The First Quarter Ended On June 302026 And To Transact Other Businesses | - |
| 2026-08-03 | Resignation Of Internal Auditor | - |